QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.108.143040v1 328/3/682    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cordeaux, Y. Articles by Smith, G. C. S. Search for Related Content PubMed PubMed Citation Articles by Cordeaux, Y. Articles by Smith, G. C. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Pregnancy

CELLULAR AND MOLECULAR

Characterization of Serotonin Receptors in Pregnant Human Myometrium

Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, United Kingdom

The monoamine, 5-hydroxytryptamine (5-HT), stimulates contraction of human uterine smooth muscle (myometrium), but the receptor subtypes involved have not been characterized. We studied the effects of a range of 5-HT receptor subtype-selective agonists and antagonists in isolated strips of myometrium obtained at the time of caesarean section. The 5-HT_1A receptor agonist, 8-hydroxy-2-dipropylaminotetralin, produced an increase in contractions that was highly variable, of low potency, and was not significantly inhibited by the 5-HT_1A antagonist WAY100635 [[O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide]. The 5-HT₂ receptor agonist, -methyl-5-hydroxytryptamine (-Me-5-HT), produced a strong, consistent, and concentration-dependent stimulation of contractions (pEC₅₀ = 7.60 ± 0.10, n = 5). The 5-HT_2A receptor antagonist, ketanserin [3-[2-[4-(4-fluoro benzoyl)-piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione], caused a parallel shift in the response to -Me-5-HT, with a pK_B value consistent with its known affinity for the 5-HT_2A receptor (pK_B = 8.47 ± 0.16, n = 5), but it had no effect on the response to oxytocin. The 5-HT_2B and 5-HT_2C receptor agonists, BW723C86 [(-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine)] and Ro-60-01-75 [(S)-2-(6-chloro-5-fluoro-indol-1-yl)-1-methyl-ethylamine fumarate], produced inconsistent responses at potencies that were lower than expected for activation of their cognate receptors. The response to -Me-5-HT was unaffected by the 5-HT_2B and 5-HT_2C receptor antagonists, SB204741 [(N-(1-methyl-1H-indolyl-5-yl)-N-(3-methyl-5-isothiazolyl)urea)] and RS102221 [8-[5-(2,4-dimethoxy-5-(4-trifluoromethyl phenylsulphonamido)phenyl-5-oxopentyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione]. The 5-HT_1B/1D receptor agonist, sumatriptan [1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide], the 5-HT₄ agonist, cisapride [4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-2-methoxy-benzamide], and the 5-HT₇ agonist, AS19 [(2S)-(+)-5-(1,3,5-trimethylpyrazol-4-yl)-2-(dimethylamino)tetralin], all had no effect on myometrial contractility. 5-HT_2A receptor mRNA and immunoreactivity were identified using reverse transcriptase-polymerase chain reaction, Western blotting, and immunohistochemistry. Specific binding of [³H]ketanserin was demonstrated. This study provides strong evidence for the expression of contractile 5-HT_2A receptors in pregnant human myometrium, and this receptor is a potential target for novel uterotonic therapies.

Address correspondence to: Dr. Yolande Cordeaux, University of Cambridge, Department of Obstetrics and Gynaecology, Level 2, The Rosie Hospital (Addenbrooke's Box 223), Robinson Way, Cambridge CB2 2SW, UK. E-mail: yc265{at}cam.ac.uk